{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:PDE4",
      "entity_text" : "PDE4",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P07288",
      "entity_text" : "PsA",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Apremilast is an oral small molecule used for PsA and psoriasis that inhibits phosphodiesterase-4 (PDE4), an enzyme that regulates intracellular levels of cyclic AMP and thus the synthesis of effector and regulatory cytokines.",
  "reading_complete" : "2020-07-28T17:07:30Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T17:01:17Z",
  "trigger" : "inhibits",
  "evidence" : [ "PsA and psoriasis that inhibits phosphodiesterase-4 (PDE4" ],
  "pmc_id" : "7211212",
  "score" : 0
}